{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2015:P56QAMMWPSSLFFEYJXNSDOEHVG","short_pith_number":"pith:P56QAMMW","canonical_record":{"source":{"id":"1509.07913","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2015-09-25T22:36:22Z","cross_cats_sorted":[],"title_canon_sha256":"884b0bbdc519a67bf4a42f59655d9f4e630d68528389f751eba26adca15fbff9","abstract_canon_sha256":"1bd50711ae20aaf14df358316107968a9a3a4cdb494d988dcc67daf5e0ee2e17"},"schema_version":"1.0"},"canonical_sha256":"7f7d0031967ca4b294984ddb21b887a99d64cc19673595c599da9483b000bc09","source":{"kind":"arxiv","id":"1509.07913","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1509.07913","created_at":"2026-05-17T23:58:50Z"},{"alias_kind":"arxiv_version","alias_value":"1509.07913v1","created_at":"2026-05-17T23:58:50Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1509.07913","created_at":"2026-05-17T23:58:50Z"},{"alias_kind":"pith_short_12","alias_value":"P56QAMMWPSSL","created_at":"2026-05-18T12:29:34Z"},{"alias_kind":"pith_short_16","alias_value":"P56QAMMWPSSLFFEY","created_at":"2026-05-18T12:29:34Z"},{"alias_kind":"pith_short_8","alias_value":"P56QAMMW","created_at":"2026-05-18T12:29:34Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2015:P56QAMMWPSSLFFEYJXNSDOEHVG","target":"record","payload":{"canonical_record":{"source":{"id":"1509.07913","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2015-09-25T22:36:22Z","cross_cats_sorted":[],"title_canon_sha256":"884b0bbdc519a67bf4a42f59655d9f4e630d68528389f751eba26adca15fbff9","abstract_canon_sha256":"1bd50711ae20aaf14df358316107968a9a3a4cdb494d988dcc67daf5e0ee2e17"},"schema_version":"1.0"},"canonical_sha256":"7f7d0031967ca4b294984ddb21b887a99d64cc19673595c599da9483b000bc09","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-17T23:58:50.628147Z","signature_b64":"9l0TtQ81NIHtkdA0BYsdZeeDH1LxufSKFRVpqENh2OOvjX381AgNs2Gi3WVp+C59xi7/gjxop3WvZpcMkGMWCA==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"7f7d0031967ca4b294984ddb21b887a99d64cc19673595c599da9483b000bc09","last_reissued_at":"2026-05-17T23:58:50.627679Z","signature_status":"signed_v1","first_computed_at":"2026-05-17T23:58:50.627679Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1509.07913","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-17T23:58:50Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"AC5poVefhGtuhKgwbh4KsBUIS8chjAf1eil4aeEbxyo7j3K7HxU+lWrAvD82kgFIKXGufxZBxYADwJZWV1KGCA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-07-02T08:38:56.753356Z"},"content_sha256":"a8c1dc3f04d7ad5a39738b7fef43dfc871f82aaf3b46ea1068cbcd0984119b2e","schema_version":"1.0","event_id":"sha256:a8c1dc3f04d7ad5a39738b7fef43dfc871f82aaf3b46ea1068cbcd0984119b2e"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2015:P56QAMMWPSSLFFEYJXNSDOEHVG","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Clinical trial design enabling {\\epsilon}-optimal treatment rules","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"stat.ME","authors_text":"Aleksey Tetenov, Charles F. Manski","submitted_at":"2015-09-25T22:36:22Z","abstract_excerpt":"Medical research has evolved conventions for choosing sample size in randomized clinical trials that rest on the theory of hypothesis testing. Bayesians have argued that trials should be designed to maximize subjective expected utility in settings of clinical interest. This perspective is compelling given a credible prior distribution on treatment response, but Bayesians have struggled to provide guidance on specification of priors. We use the frequentist statistical decision theory of Wald (1950) to study design of trials under ambiguity. We show that {\\epsilon}-optimal rules exist when trial"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1509.07913","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-17T23:58:50Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"lPiFL1z1Alioz/jMNrmIUGdH3LSqtcOv7QtoecRdkOnFU5LH9fLUTbZ2lt6HSGQJ80ZzmW7G/n+IxN8dSViiDw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-07-02T08:38:56.753708Z"},"content_sha256":"b80265c0ba5f3828f1d10178643a681f1864ed4177a4a640de40085e58f95f98","schema_version":"1.0","event_id":"sha256:b80265c0ba5f3828f1d10178643a681f1864ed4177a4a640de40085e58f95f98"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/P56QAMMWPSSLFFEYJXNSDOEHVG/bundle.json","state_url":"https://pith.science/pith/P56QAMMWPSSLFFEYJXNSDOEHVG/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/P56QAMMWPSSLFFEYJXNSDOEHVG/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-07-02T08:38:56Z","links":{"resolver":"https://pith.science/pith/P56QAMMWPSSLFFEYJXNSDOEHVG","bundle":"https://pith.science/pith/P56QAMMWPSSLFFEYJXNSDOEHVG/bundle.json","state":"https://pith.science/pith/P56QAMMWPSSLFFEYJXNSDOEHVG/state.json","well_known_bundle":"https://pith.science/.well-known/pith/P56QAMMWPSSLFFEYJXNSDOEHVG/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2015:P56QAMMWPSSLFFEYJXNSDOEHVG","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"1bd50711ae20aaf14df358316107968a9a3a4cdb494d988dcc67daf5e0ee2e17","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2015-09-25T22:36:22Z","title_canon_sha256":"884b0bbdc519a67bf4a42f59655d9f4e630d68528389f751eba26adca15fbff9"},"schema_version":"1.0","source":{"id":"1509.07913","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1509.07913","created_at":"2026-05-17T23:58:50Z"},{"alias_kind":"arxiv_version","alias_value":"1509.07913v1","created_at":"2026-05-17T23:58:50Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1509.07913","created_at":"2026-05-17T23:58:50Z"},{"alias_kind":"pith_short_12","alias_value":"P56QAMMWPSSL","created_at":"2026-05-18T12:29:34Z"},{"alias_kind":"pith_short_16","alias_value":"P56QAMMWPSSLFFEY","created_at":"2026-05-18T12:29:34Z"},{"alias_kind":"pith_short_8","alias_value":"P56QAMMW","created_at":"2026-05-18T12:29:34Z"}],"graph_snapshots":[{"event_id":"sha256:b80265c0ba5f3828f1d10178643a681f1864ed4177a4a640de40085e58f95f98","target":"graph","created_at":"2026-05-17T23:58:50Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Medical research has evolved conventions for choosing sample size in randomized clinical trials that rest on the theory of hypothesis testing. Bayesians have argued that trials should be designed to maximize subjective expected utility in settings of clinical interest. This perspective is compelling given a credible prior distribution on treatment response, but Bayesians have struggled to provide guidance on specification of priors. We use the frequentist statistical decision theory of Wald (1950) to study design of trials under ambiguity. We show that {\\epsilon}-optimal rules exist when trial","authors_text":"Aleksey Tetenov, Charles F. Manski","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2015-09-25T22:36:22Z","title":"Clinical trial design enabling {\\epsilon}-optimal treatment rules"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1509.07913","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:a8c1dc3f04d7ad5a39738b7fef43dfc871f82aaf3b46ea1068cbcd0984119b2e","target":"record","created_at":"2026-05-17T23:58:50Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"1bd50711ae20aaf14df358316107968a9a3a4cdb494d988dcc67daf5e0ee2e17","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"stat.ME","submitted_at":"2015-09-25T22:36:22Z","title_canon_sha256":"884b0bbdc519a67bf4a42f59655d9f4e630d68528389f751eba26adca15fbff9"},"schema_version":"1.0","source":{"id":"1509.07913","kind":"arxiv","version":1}},"canonical_sha256":"7f7d0031967ca4b294984ddb21b887a99d64cc19673595c599da9483b000bc09","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"7f7d0031967ca4b294984ddb21b887a99d64cc19673595c599da9483b000bc09","first_computed_at":"2026-05-17T23:58:50.627679Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-17T23:58:50.627679Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"9l0TtQ81NIHtkdA0BYsdZeeDH1LxufSKFRVpqENh2OOvjX381AgNs2Gi3WVp+C59xi7/gjxop3WvZpcMkGMWCA==","signature_status":"signed_v1","signed_at":"2026-05-17T23:58:50.628147Z","signed_message":"canonical_sha256_bytes"},"source_id":"1509.07913","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:a8c1dc3f04d7ad5a39738b7fef43dfc871f82aaf3b46ea1068cbcd0984119b2e","sha256:b80265c0ba5f3828f1d10178643a681f1864ed4177a4a640de40085e58f95f98"],"state_sha256":"51a40aef96dc31362a9059395d15089fdd6b523b6063a7ad008d9ff91bbd47b0"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"NYq91UTgh4XoTHiAf23725yc6cfsDSxuYNKX64I2smX4b4IRylG5IPfHd/tuG2ySSdGJ7/9LI97EBabHjWUfBQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-07-02T08:38:56.755630Z","bundle_sha256":"7de106ab5e32e0f2496ed12d04f051725c8ff29935b97167e3fbfdb0882058e8"}}